Ford et al. demonstrated in CAF-like phenotype tumor mice that NADPH oxidase 4 (NOX4) inhibition effectively reverses CAF-mediated CD8+ T cell exclusion, resulting in markedly improved responses to immunotherapy[45]. This evidence concerns the gene CD8A and neoplasm.